Screening for EGFR Mutations in Patients with Head and Neck Cancer Treated with Gefitinib on a Compassionate-Use Program: A Hellenic Cooperative Oncology Group Study.
about
Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancerMutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment responseAn Inducible TGF-β2-TGFβR Pathway Modulates the Sensitivity of HNSCC Cells to Tyrosine Kinase Inhibitors Targeting Dominant Receptor Tyrosine Kinases.Personalized therapy in endometrial cancer: challenges and opportunities.Tyrosine kinase domain mutations of EGFR gene in head and neck squamous cell carcinoma.Anti-epidermal growth factor receptor therapy in head and neck squamous cell carcinoma: focus on potential molecular mechanisms of drug resistanceTherapy of advanced squamous cell carcinoma of the skin.In vitro study of normoxic epidermal growth factor receptor-induced hypoxia-inducible factor-1-alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti-epidermal growtPrevalence of EGFR Tyrosine Kinase Domain Mutations in Head and Neck Squamous Cell Carcinoma: Cohort Study and Systematic Review.Assessment of EGFR/HER2 dimerization by FRET-FLIM utilizing Alexa-conjugated secondary antibodies in relation to targeted therapies in cancers.
P2860
Q26852215-A5F7D30A-8FD0-41AD-83E1-C4A33D509A89Q31162700-DB4525DF-EE3B-4BA3-AF55-2C5C2103BA5EQ35577672-BE13F09A-A49B-4015-892E-DADA2B027DCEQ35911350-20388E36-CEF0-42E7-9D3D-4B82BB027C27Q37712380-AF893416-BEFC-4135-8573-BC4D50302E53Q38118934-62018598-3F4E-4D70-8B40-4EE9D4947A40Q38197119-27CFF9BD-DC7F-430C-A334-E3CCF9A92FEDQ38998235-5B2F58A6-5FEF-4861-A808-C254C5C83943Q39073840-CE1467AB-D182-4648-949E-1E2B9A439461Q39475977-7055FD4A-ABFC-4981-B91D-6D0272BFCEFC
P2860
Screening for EGFR Mutations in Patients with Head and Neck Cancer Treated with Gefitinib on a Compassionate-Use Program: A Hellenic Cooperative Oncology Group Study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Screening for EGFR Mutations i ...... perative Oncology Group Study.
@ast
Screening for EGFR Mutations i ...... perative Oncology Group Study.
@en
Screening for EGFR Mutations i ...... perative Oncology Group Study.
@nl
type
label
Screening for EGFR Mutations i ...... perative Oncology Group Study.
@ast
Screening for EGFR Mutations i ...... perative Oncology Group Study.
@en
Screening for EGFR Mutations i ...... perative Oncology Group Study.
@nl
prefLabel
Screening for EGFR Mutations i ...... perative Oncology Group Study.
@ast
Screening for EGFR Mutations i ...... perative Oncology Group Study.
@en
Screening for EGFR Mutations i ...... perative Oncology Group Study.
@nl
P2093
P2860
P356
P1433
P1476
Screening for EGFR Mutations i ...... perative Oncology Group Study.
@en
P2093
Angelos Nikolaou
Evangelia Razis
Helena Linardou
Mattheos Bobos
Nikolaos Angouridakis
Samuel Murray
P2860
P304
P356
10.1155/2010/709678
P577
2010-01-01T00:00:00Z